1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Bone Metastasis Global Clinical Trials Review, H1, 2015

Bone Metastasis Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 179 pages

Bone Metastasis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2015" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Metastasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Bone Metastasis Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Bone Metastasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bone Metastasis to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bone Metastasis to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bone Metastasis 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Bone Metastasis Therapeutics Clinical Trials 33
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Amgen Inc. 41
Clinical Trial Overview of Amgen Inc. 41
F. Hoffmann-La Roche Ltd. 43
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 43
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
AstraZeneca PLC 47
Clinical Trial Overview of AstraZeneca PLC 47
Merck and Co., Inc. 48
Clinical Trial Overview of Merck and Co., Inc. 48
Pfizer Inc. 49
Clinical Trial Overview of Pfizer Inc. 49
AbbVie Inc. 50
Clinical Trial Overview of AbbVie Inc. 50
Galil Medical Ltd. 51
Clinical Trial Overview of Galil Medical Ltd. 51
Exelixis, Inc. 52
Clinical Trial Overview of Exelixis, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 53
University Health Network 54
Clinical Trial Overview of University Health Network 54
National Cancer Institute 55
Clinical Trial Overview of National Cancer Institute 55
SWOG 56
Clinical Trial Overview of SWOG 56
West China Hospital 57
Clinical Trial Overview of West China Hospital 57
Washington University School of Medicine 58
Clinical Trial Overview of Washington University School of Medicine 58
Massachusetts General Hospital 59
Clinical Trial Overview of Massachusetts General Hospital 59
Radiation Therapy Oncology Group 60
Clinical Trial Overview of Radiation Therapy Oncology Group 60
Sun Yat-sen University 61
Clinical Trial Overview of Sun Yat-sen University 61
Memorial Sloan Kettering Cancer Center 62
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 62
Five Key Clinical Profiles 63
Appendix 177
Abbreviations 177
Definitions 177
Research Methodology 178
Secondary Research 178
About GlobalData 179
Contact Us 179
Disclaimer 179
Source 179

List of Tables
Bone Metastasis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Bone Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Bone Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Bone Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Bone Metastasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Bone Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Bone Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Bone Metastasis to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Bone Metastasis to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Bone Metastasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Bone Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Bone Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Bone Metastasis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Bone Metastasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Bone Metastasis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Bone Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Bone Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31
Bone Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Bone Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Bone Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 35
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 41
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 43
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 45
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 47
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 48
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 49
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 50
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galil Medical Ltd., 2015* 51
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2015* 52
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 53
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 54
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 55
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015* 56
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2015* 57
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2015* 58
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 59
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015* 60
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 61
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 62

List of Figures
Bone Metastasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Bone Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Bone Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Bone Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Bone Metastasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Bone Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Bone Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Bone Metastasis to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Bone Metastasis to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Bone Metastasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Bone Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Bone Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Bone Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Bone Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31
Bone Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Bone Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Bone Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
GlobalData Methodology 178

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.